Atai Life Sciences EPS - Earnings per Share 2020-2025 | ATAI
Atai Life Sciences eps - earnings per share from 2020 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Atai Life Sciences Annual EPS |
| 2024 |
$-0.93 |
| 2023 |
$-0.25 |
| 2022 |
$-0.98 |
| 2021 |
$-1.21 |
| 2020 |
$-1.83 |
| 2019 |
$-0.16 |
| Atai Life Sciences Quarterly EPS |
| 2025-03-31 |
$-0.15 |
| 2024-12-31 |
$-0.24 |
| 2024-09-30 |
$-0.16 |
| 2024-06-30 |
$-0.36 |
| 2024-03-31 |
$-0.17 |
| 2023-12-31 |
$-0.08 |
| 2023-09-30 |
$0.25 |
| 2023-06-30 |
$-0.21 |
| 2023-03-31 |
$-0.21 |
| 2022-12-31 |
$-0.28 |
| 2022-09-30 |
$-0.22 |
| 2022-06-30 |
$-0.24 |
| 2022-03-31 |
$-0.24 |
| 2021-12-31 |
$-0.64 |
| 2021-09-30 |
$-0.21 |
| 2021-06-30 |
$-0.37 |
| 2021-03-31 |
$0.01 |
| 2020-12-31 |
$-0.89 |
| 2020-09-30 |
$-0.92 |
| 2020-06-30 |
$-0.18 |
| 2020-03-31 |
$0.16 |
| 2019-12-31 |
$0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.545B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
